Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial

Title
Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial
Authors
Keywords
Anthracycline, Cardiac toxicity, Diffuse large B-cell lymphoma, Elderly patients, Pegylated liposomal doxorubicin
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume 15, Issue 3, Pages 152-158
Publisher
Elsevier BV
Online
2014-09-29
DOI
10.1016/j.clml.2014.09.001

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now